<p>根据最近向证券交易委员会的披露，Sequoia Financial Advisors LLC 在第四季度将其在 Align Technology, Inc.（NASDAQ:ALGN - 免费报告）股票中的持股比例提高了 320.1%。该机构投资者在季度内购买了 6,085 股后，持有 7,986 股该医疗设备提供商的股票。根据其最近向证券交易委员会的备案，Sequoia Financial Advisors LLC 在 Align Technology 的持股价值为 1,247,000 美元。</p>
<p>获取 <strong>Align Technology</strong> 的提醒：</p>
<ul>
<li>为什么这三只科技股票可能是你忽视的最佳机会</li>
</ul>
<p>其他一些机构投资者最近也增加或减少了对该股票的持股。Capital International Investors 在第三季度将其在 Align Technology 的持股比例提高了 88.6%。Capital International Investors 现在拥有 3,050,373 股该医疗设备提供商的股票，价值 381,968,000 美元，在上个季度又购买了 1,433,393 股。Holocene Advisors LP 在第三季度获得了 Align Technology 的新头寸，价值 179,035,000 美元。美国银行在第三季度将其在 Align Technology 的持股比例提高了 72.0%。美国银行现在拥有 1,353,125 股该医疗设备提供商的股票，价值 169,438,000 美元，在上个季度又购买了 566,488 股。Invesco Ltd.在第三季度将其在 Align Technology 的持股比例提高了 37.4%。Invesco Ltd.现在拥有 1,497,535 股该医疗设备提供商的股票，价值 187,521,000 美元，在上个季度又购买了 407,559 股。最后，瑞银集团在第三季度将其在 Align Technology 的持股比例提高了 122.4%。瑞银集团现在拥有 581,307 股该医疗设备提供商的股票，价值 72,791,000 美元，在上个季度又购买了 319,908 股。88.43% 的股票由机构投资者和对冲基金持有。</p>
<h2>内部人士下注</h2>
<p>在其他 Align Technology 的新闻中，执行副总裁 John Morici 于 2 月 18 日星期三出售了 7,969 股该股票。股票以平均价格 189.31 美元出售，总价值为 1,508,611.39 美元。交易后，该执行副总裁直接持有 8,237 股公司的股票，价值 1,559,346.47 美元。这代表其持股减少了 49.17%。该交易在向证券交易委员会的法律文件中披露，文件可通过此超链接获取。当前 0.75% 的股票由公司内部人士持有。</p>
<h2>分析师设定新目标价</h2>
<ul>
<li>买入抄底？这些盈利失误提供长期上涨潜力</li>
</ul>
<p>几位研究分析师对该公司发布了报告。摩根士丹利将 Align Technology 的目标价从 169.00 美元上调至 188.00 美元，并在 4 月 24 日的报告中给予该股票 “持平” 评级。巴克莱将 Align Technology 的评级从 “持平” 上调至 “增持”，并在 3 月 17 日的报告中设定了 200.00 美元的目标价。瑞穗将 Align Technology 的目标价从 200.00 美元上调至 215.00 美元，并在 2 月 5 日的报告中给予该股票 “跑赢大盘” 评级。杰富瑞金融集团将 Align Technology 的目标价从 155.00 美元上调至 185.00 美元，并在 2 月 5 日的研究报告中给予该公司 “持有” 评级。最后，罗伯特·W·贝尔德在 2 月 5 日的研究报告中设定了 Align Technology 的目标价为 218.00 美元。八位投资分析师对该股票给予了买入评级，六位分析师对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，Align Technology 的共识评级为 “适度买入”，共识目标价为 205.85 美元。</p>
<p><strong>查看我们对 ALGN 的最新分析</strong></p>
<h2>Align Technology 价格表现</h2>
<ul>
<li>MarketBeat 周回顾：12/25 - 12/29</li>
</ul>
<p>Align Technology 的股票在星期三开盘价为 165.79 美元。该公司的 50 日移动平均线为 176.74 美元，200 日移动平均线为 166.00 美元。Align Technology, Inc.的股价在一年内最低为 122.00 美元，最高为 208.30 美元。该公司的市值为 118.7 亿美元，市盈率为 27.82，市盈增长比率为 1.69，贝塔值为 1.70。</p>
<p>Align Technology（NASDAQ:ALGN - 获取免费报告）最近于 4 月 29 日发布了季度财报。该医疗设备提供商报告季度每股收益为 2.58 美元，超出分析师共识预期的 2.26 美元，超出幅度为 0.32 美元。Align Technology 的净利润率为 10.50%，股本回报率为 15.82%。该公司在季度内的收入为 10.4 亿美元，而共识预期为 10.2 亿美元。在去年同期，该公司发布的每股收益为 2.13 美元。该公司的季度收入同比增长 6.2%。整体来看，卖方分析师预计 Align Technology, Inc.在当前年度将发布每股收益 9.47 美元。</p>
<p>Align Technology 宣布其董事会已于 4 月 29 日批准了一项股票回购计划，允许公司回购 2 亿美元的流通股。该回购授权允许该医疗设备提供商通过公开市场购买最多 1.6% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>Align Technology 公司简介</h2>
<p>（免费报告）</p>
<p>Align Technology, Inc. NASDAQ: ALGN 通过开发 Invisalign 系统，开创了数字技术在正畸学中的应用，该系统是一系列透明、可拆卸的矫正器，为传统金属牙套提供了一种替代方案。自 1997 年由 Zia Chishti 和 Kelsey Wirth 创立以来，总部位于亚利桑那州坦佩的公司已将其关注点扩展到包括口腔内扫描仪、牙科实验室的 CAD/CAM 软件和全面的数字牙科解决方案。</p>
<p>公司的标志性 Invisalign 系统利用 3D 成像和计算机辅助设计 (CAD) 创建定制的矫正器，逐渐重新定位牙齿，提高患者的舒适度和治疗的可预测性。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们认为比 Align Technology 更好的股票</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河第一季度业绩不佳而暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在盈利后大幅上涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Align Technology 吗？</h2>
<p>在考虑 Align Technology 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已确定五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Align Technology 并不在名单上。</p>
<p>虽然 Align Technology 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

爱齐科技

标普健康医疗设备 ETF - SPDR

医疗业 ETF - SPDR

美国医药设备 ETF - iShares

<p>Sequoia Financial Advisors LLC 在第四季度将其在 Align Technology, Inc. (NASDAQ:ALGN) 的持股增加了 320.1%，目前持有 7,986 股，价值 125 万美元。其他机构投资者也增加了他们的持股，Capital International Investors 的持股增加了 88.6%。分析师们为 Align Technology 设定了新的价格目标，普遍目标为 205.85 美元。该股票开盘价为 165.79 美元，市值为 118.7 亿美元，市盈率为 27.82。Align 在上个季度报告的每股收益为 2.58 美元，超出预期</p>

<p>Sequoia Financial Advisors LLC raised its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 320.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,986 shares of the medical equipment provider's stock after purchasing an additional 6,085 shares during the quarter. Sequoia Financial Advisors LLC's holdings in Align Technology were worth $1,247,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>根据最近向证券交易委员会的披露，Sequoia Financial Advisors LLC 在第四季度将其在 Align Technology, Inc.（NASDAQ:ALGN - 免费报告）股票中的持股比例提高了 320.1%。该机构投资者在季度内购买了 6,085 股后，持有 7,986 股该医疗设备提供商的股票。根据其最近向证券交易委员会的备案，Sequoia Financial Advisors LLC 在 Align Technology 的持股价值为 1,247,000 美元。</p>
</div><p>Get <strong>Align Technology</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Align Technology</strong> 的提醒：</p>
</div><ul>
<li>Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么这三只科技股票可能是你忽视的最佳机会</li>
</ul>
</div><p>A number of other institutional investors also recently added to or reduced their stakes in the stock. Capital International Investors boosted its holdings in shares of Align Technology by 88.6% in the 3rd quarter. Capital International Investors now owns 3,050,373 shares of the medical equipment provider's stock worth $381,968,000 after acquiring an additional 1,433,393 shares in the last quarter. Holocene Advisors LP acquired a new position in Align Technology during the 3rd quarter worth $179,035,000. Bank of America Corp DE lifted its holdings in Align Technology by 72.0% during the 3rd quarter. Bank of America Corp DE now owns 1,353,125 shares of the medical equipment provider's stock worth $169,438,000 after buying an additional 566,488 shares in the last quarter. Invesco Ltd. lifted its holdings in Align Technology by 37.4% during the 3rd quarter. Invesco Ltd. now owns 1,497,535 shares of the medical equipment provider's stock worth $187,521,000 after buying an additional 407,559 shares in the last quarter. Finally, UBS Group AG lifted its holdings in Align Technology by 122.4% during the 3rd quarter. UBS Group AG now owns 581,307 shares of the medical equipment provider's stock worth $72,791,000 after buying an additional 319,908 shares in the last quarter. 88.43% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些机构投资者最近也增加或减少了对该股票的持股。Capital International Investors 在第三季度将其在 Align Technology 的持股比例提高了 88.6%。Capital International Investors 现在拥有 3,050,373 股该医疗设备提供商的股票，价值 381,968,000 美元，在上个季度又购买了 1,433,393 股。Holocene Advisors LP 在第三季度获得了 Align Technology 的新头寸，价值 179,035,000 美元。美国银行在第三季度将其在 Align Technology 的持股比例提高了 72.0%。美国银行现在拥有 1,353,125 股该医疗设备提供商的股票，价值 169,438,000 美元，在上个季度又购买了 566,488 股。Invesco Ltd.在第三季度将其在 Align Technology 的持股比例提高了 37.4%。Invesco Ltd.现在拥有 1,497,535 股该医疗设备提供商的股票，价值 187,521,000 美元，在上个季度又购买了 407,559 股。最后，瑞银集团在第三季度将其在 Align Technology 的持股比例提高了 122.4%。瑞银集团现在拥有 581,307 股该医疗设备提供商的股票，价值 72,791,000 美元，在上个季度又购买了 319,908 股。88.43% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other Align Technology news, EVP John Morici sold 7,969 shares of the stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total value of $1,508,611.39. Following the transaction, the executive vice president directly owned 8,237 shares of the company's stock, valued at $1,559,346.47. This represents a 49.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. 0.75% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Align Technology 的新闻中，执行副总裁 John Morici 于 2 月 18 日星期三出售了 7,969 股该股票。股票以平均价格 189.31 美元出售，总价值为 1,508,611.39 美元。交易后，该执行副总裁直接持有 8,237 股公司的股票，价值 1,559,346.47 美元。这代表其持股减少了 49.17%。该交易在向证券交易委员会的法律文件中披露，文件可通过此超链接获取。当前 0.75% 的股票由公司内部人士持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><ul>
<li>Buy the Dip? These Earnings Misses Offer Long-Term Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>买入抄底？这些盈利失误提供长期上涨潜力</li>
</ul>
</div><p>Several research analysts have issued reports on the company. Morgan Stanley upped their price objective on Align Technology from $169.00 to $188.00 and gave the stock an &#34;equal weight&#34; rating in a report on Friday, April 24th. Barclays raised Align Technology from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and set a $200.00 price objective on the stock in a report on Tuesday, March 17th. Mizuho upped their price objective on Align Technology from $200.00 to $215.00 and gave the stock an &#34;outperform&#34; rating in a report on Thursday, February 5th. Jefferies Financial Group upped their target price on shares of Align Technology from $155.00 to $185.00 and gave the company a &#34;hold&#34; rating in a research report on Thursday, February 5th. Finally, Robert W. Baird set a $218.00 target price on shares of Align Technology in a research report on Thursday, February 5th. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Align Technology has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $205.85.</p>
<div class="lb-trans"><p>几位研究分析师对该公司发布了报告。摩根士丹利将 Align Technology 的目标价从 169.00 美元上调至 188.00 美元，并在 4 月 24 日的报告中给予该股票 “持平” 评级。巴克莱将 Align Technology 的评级从 “持平” 上调至 “增持”，并在 3 月 17 日的报告中设定了 200.00 美元的目标价。瑞穗将 Align Technology 的目标价从 200.00 美元上调至 215.00 美元，并在 2 月 5 日的报告中给予该股票 “跑赢大盘” 评级。杰富瑞金融集团将 Align Technology 的目标价从 155.00 美元上调至 185.00 美元，并在 2 月 5 日的研究报告中给予该公司 “持有” 评级。最后，罗伯特·W·贝尔德在 2 月 5 日的研究报告中设定了 Align Technology 的目标价为 218.00 美元。八位投资分析师对该股票给予了买入评级，六位分析师对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，Align Technology 的共识评级为 “适度买入”，共识目标价为 205.85 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on ALGN</strong></p>
<div class="lb-trans"><p><strong>查看我们对 ALGN 的最新分析</strong></p>
</div><h2>Align Technology Price Performance</h2>
<div class="lb-trans"><h2>Align Technology 价格表现</h2>
</div><ul>
<li>MarketBeat Week in Review: 12/25 - 12/29</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾：12/25 - 12/29</li>
</ul>
</div><p>Align Technology stock opened at $165.79 on Wednesday. The firm has a 50-day moving average of $176.74 and a 200-day moving average of $166.00. Align Technology, Inc. has a one year low of $122.00 and a one year high of $208.30. The company has a market cap of $11.87 billion, a price-to-earnings ratio of 27.82, a P/E/G ratio of 1.69 and a beta of 1.70.</p>
<div class="lb-trans"><p>Align Technology 的股票在星期三开盘价为 165.79 美元。该公司的 50 日移动平均线为 176.74 美元，200 日移动平均线为 166.00 美元。Align Technology, Inc.的股价在一年内最低为 122.00 美元，最高为 208.30 美元。该公司的市值为 118.7 亿美元，市盈率为 27.82，市盈增长比率为 1.69，贝塔值为 1.70。</p>
</div><p>Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The medical equipment provider reported $2.58 EPS for the quarter, topping analysts' consensus estimates of $2.26 by $0.32. Align Technology had a net margin of 10.50% and a return on equity of 15.82%. The company had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the prior year, the business posted $2.13 EPS. The company's quarterly revenue was up 6.2% on a year-over-year basis. As a group, sell-side analysts expect that Align Technology, Inc. will post 9.47 earnings per share for the current year.</p>
<div class="lb-trans"><p>Align Technology（NASDAQ:ALGN - 获取免费报告）最近于 4 月 29 日发布了季度财报。该医疗设备提供商报告季度每股收益为 2.58 美元，超出分析师共识预期的 2.26 美元，超出幅度为 0.32 美元。Align Technology 的净利润率为 10.50%，股本回报率为 15.82%。该公司在季度内的收入为 10.4 亿美元，而共识预期为 10.2 亿美元。在去年同期，该公司发布的每股收益为 2.13 美元。该公司的季度收入同比增长 6.2%。整体来看，卖方分析师预计 Align Technology, Inc.在当前年度将发布每股收益 9.47 美元。</p>
</div><p>Align Technology declared that its Board of Directors has approved a stock buyback program on Wednesday, April 29th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to purchase up to 1.6% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>Align Technology 宣布其董事会已于 4 月 29 日批准了一项股票回购计划，允许公司回购 2 亿美元的流通股。该回购授权允许该医疗设备提供商通过公开市场购买最多 1.6% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>Align Technology Company Profile</h2>
<div class="lb-trans"><h2>Align Technology 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Align Technology, Inc NASDAQ: ALGN pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.</p>
<div class="lb-trans"><p>Align Technology, Inc. NASDAQ: ALGN 通过开发 Invisalign 系统，开创了数字技术在正畸学中的应用，该系统是一系列透明、可拆卸的矫正器，为传统金属牙套提供了一种替代方案。自 1997 年由 Zia Chishti 和 Kelsey Wirth 创立以来，总部位于亚利桑那州坦佩的公司已将其关注点扩展到包括口腔内扫描仪、牙科实验室的 CAD/CAM 软件和全面的数字牙科解决方案。</p>
</div><p>The company's signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.</p>
<div class="lb-trans"><p>公司的标志性 Invisalign 系统利用 3D 成像和计算机辅助设计 (CAD) 创建定制的矫正器，逐渐重新定位牙齿，提高患者的舒适度和治疗的可预测性。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Align Technology</li>
<li>Navy Catalyst Ignites Odysight’s Growth Engine</li>
<li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li>
<li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li>
<li>The Event That Could Redefine Apple’s Summer Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Align Technology 更好的股票</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河第一季度业绩不佳而暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在盈利后大幅上涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ALGN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Align Technology Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Align Technology 吗？</h2>
</div><p>Before you consider Align Technology, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Align Technology 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已确定五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Align Technology 并不在名单上。</p>
</div><p>While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Align Technology 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Sequoia Financial Advisors LLC Has $1.25 Million Stock Position in Align Technology, Inc. $ALGN

Market Beat

美国银行

景顺投资管理

瑞银集团

摩根士丹利

巴克莱银行

瑞穗金融集团

Mizuho Financial Group, Inc.

Jefferies Financial

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

红杉金融顾问有限公司在爱齐科技公司持有价值 125 万美元的股票头寸